Wistar Wire: Melanoma

In this latest NIH project grant, The Wistar Institute's Dr. Meenhard Herlyn brings together cutting-edge scientists from Wistar and the University of Pennsylvania to tackle melanoma drug resistance.
Cancer, Funding, Melanoma
Ben Leach
Ashani Weeraratna, Ph.D.
Ashani Weeraratna, Ph.D.
Wistar researchers have identified a pathway associated with melanoma becoming metastatic, or spreading to other organs, and what causes the pathway to make tumor cells more likely to be invasive.
In the current issue of the journal Cancer Cell, Wistar research describe how a drug developed against diabetes might improve the performance of anti-melanoma drugs.
Cancer, Melanoma
On May 19th, 2013, The Wistar Institute hosted Melanoma Awareness Day at Citizens Bank Park, presented by Citizens Bank and Independence Blue Cross.
Events, Melanoma